Skip to content

Effects of Cycling Dual-task in Parkinson's Disease.

Effects of a Forced Cycling Program With Cognitive Stimulation on Symptomatology, Physical Condition, and Cognition in People Diagnosed With Parkinson's Disease.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05565300
Enrollment
44
Registered
2022-10-04
Start date
2022-09-15
Completion date
2023-12-15
Last updated
2024-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.

Interventions

30 minutes of cycling (90 rpm).

30 minutes of cognitive tasks based on the different domains of the Mini Mental Scale.

Sponsors

University of Vigo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Parkinson disease * Hoehn and Yahr 1 and 2

Exclusion criteria

* Hoehn and Yahr \>2

Design outcomes

Primary

MeasureTime frameDescription
Timed Up and GoChange from Baseline Timed Up and Go at 12 weeksDynamic balance
Sit to Stand testChange from Baseline Sit to Stand Test at 12 weeksLower limbs strength
Movement Disorder Society - Unified Parkinson's Disease Rating ScaleChange from Baseline Unified Parkinson's Disease Rating Scale at 12 weeks (0-159, better lower values)Parkinson's Disease rating
Parkinson's Disease Questionnaire - 39Change from Baseline Parkinson's Disease Questionnaire - 39 at 12 weeks (0-100, better lower values)Quality of life

Secondary

MeasureTime frameDescription
Trail Making Test A & BChange from Baseline Trail Making Test A & B at 12 weeksAttention, visual screening ability and processing speed
Stroop testChange from Baseline Stroop Test at 12 weeksAbility to inhibit cognitive interference

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026